A Machado-Silva, PG Cerqueira… - … Research/Reviews in …, 2016 - Elsevier
Trypanosoma cruzi, the causative agent of Chagas disease, is an obligatory intracellular parasite with a digenetic life cycle. Due to the variety of host environments, it faces several …
K Singh, G Garg, V Ali - Current drug metabolism, 2016 - ingentaconnect.com
Leishmaniasis is one of the six diseases regarded most neglected by World Health Organization which is predominant in developing countries. Clinically, among the different …
AC Mesías, NJ Garg, MP Zago - Frontiers in Cellular and Infection …, 2019 - frontiersin.org
The toxicity of oxygen and nitrogen reactive species appears to be merely the tip of the iceberg in the world of redox homeostasis. Now, oxidative stress can be seen as a two-sided …
J San Francisco, C Astudillo, JL Vega, A Catalán… - Virulence, 2022 - Taylor & Francis
The molecular repertoire of Trypanosoma cruzi effects its virulence and impacts the clinical course of the resulting Chagas disease. This study aimed to determine the mechanism …
Trypanothione is a unique and essential redox metabolite of trypanosomatid parasites, the biosynthetic pathway of which is regarded as a promising target for antiparasitic drugs …
MD Piñeyro, D Arias, A Parodi-Talice… - Current …, 2021 - ingentaconnect.com
Chagas Disease, African sleeping sickness, and leishmaniasis are neglected diseases caused by pathogenic trypanosomatid parasites, which have a considerable impact on …
V G. Duschak - Recent patents on anti-infective drug discovery, 2016 - benthamdirect.com
Background: The American trypanosomiasis, Chagas disease, is a parasitic infection typically spread by triatomine vectors affecting millions of people all over Latin America …
SS Suman, A Equbal, A Zaidi, MY Ansari, KP Singh… - Biochimie, 2016 - Elsevier
Leishmania is a unicellular protozoan parasite which causes leishmaniasis, a neglected tropical disease. It possess a unique thiol metabolism comprising of several proteins among …
There is an urgent need to develop new treatments for Chagas' disease. To identify drug targets, it is important to understand the basic biology of Trypanosoma cruzi, in particular …